QLY Biotech Group Corp. reported earnings results for the second quarter and six months ended February 28, 2023. For the second quarter, the company reported net loss was USD 0.01162 million compared to USD 0.001755 million a year ago.
For the six months, net loss was USD 0.020788 million compared to USD 0.005967 million a year ago. Basic loss per share from continuing operations was USD 0.01.